Table 2.
Subjects carrying MRSA | Subjects carrying MR-CoNS | |||
---|---|---|---|---|
n | (%) | n | (%) | |
Total | 19 | (8·4) | 123 | (54·2) |
Total nasal | 17 | (7·5) | 110 | (48·5) |
Total skin | 13 | (5·7) | 28 | (12·3) |
Exclusively nasal | 6 | (2·6) | 95 | (41·8) |
Exclusively skin | 2 | (0·9) | 13 | (5·7) |
Nasal + skin | 11 | (4·8) | 15 | (6·6) |
MRSA, Methicillin-resistant Staphylococcus aureus; MR-CoNS, methicillin-resistant coagulase-negative staphylococci.